FBIOX Mutual Fund — BIOTECHNOLOGY PORTFOLIO

BIOTECHNOLOGY PORTFOLIO (FBIOX)

Updated October 16, 2026.

FBIOX is a Mutual Fund. its distribution rate is 5.97%, its trailing-12-month yield is 5.97%, its expense ratio is 0.6024%. Dividend Vision Distribution Safety Score™ is 64/100 (Generally safe). Total return is 10509.1% over the past 40.4 years.

Fidelity Biotechnology Portfolio is a mutual fund that invests primarily in stocks of companies engaged in biotechnology research, development, manufacturing, and distribution, as well as companies that benefit from biotech advances, across both domestic and foreign markets. The fund uses fundamental analysis to select investments and is non-diversified, meaning it may hold concentrated positions in individual securities. The fund currently distributes at a modest rate on an irregular basis, with its latest distribution noted as special and not necessarily recurring.

FBIOX performance

Price and return data through 2026-10-16.

Total return is 10509.1% over the past 40.4 years. Over the past year its total return — price change plus distributions reinvested — is 23.1%. Its deepest 1-year drawdown was 14.3%.

FBIOX key facts

Distribution Safety Score™

64 · Generally safe

Issuer

Fidelity Investments

Asset type

Mutual Fund

Asset class

Equity

Inception date

05/15/1986

Expense ratio

0.6024%

Distribution rate

5.97%

Trailing yield

5.97%

Last close

$27.17 (as of 2026-10-16)

NAV

$27.09 as of 2026-09-30; source eodhd (stale)

Premium / discount

N/A (price 2026-10-16, NAV 2026-09-30) (NAV stale)

AUM

$5,977,640,000

Average volume

0.0

Dividend

$1.063

Ex-dividend date

04/10/2026

Payment date

04/13/2026

Beta

0.71

How Dividend Vision calculates yield and returns

Distribution rate (5.97%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (5.97%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: Fidelity Investments; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

FBIOX risks and drawbacks

The deepest 1-year drawdown on record here is 14.3%.

Who may consider FBIOX — and who may not

FBIOX may suit someone looking for moderate current income with a quality tilt. It is a weaker fit for investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

More on FBIOX

• All tickers starting with F

Tagged: Healthcare, Mutual Fund.

Frequently asked questions

More securities from Fidelity Investments.